PRC
Pearl River Capital Portfolio holdings
AUM
$630M
1-Year Return
17.08%
This Quarter Return
-2.93%
1 Year Return
+17.08%
3 Year Return
+20.36%
5 Year Return
+58.02%
10 Year Return
–
AUM
$538M
AUM Growth
+$114M
(+27%)
Cap. Flow
+$124M
Cap. Flow
% of AUM
23.13%
Top 10 Holdings %
Top 10 Hldgs %
12.27%
Holding
589
New
159
Increased
168
Reduced
113
Closed
148
Top Buys
| 1 |
Microsoft
MSFT
|
$6.69M |
| 2 |
Amazon
AMZN
|
$6.3M |
| 3 |
Qualcomm
QCOM
|
$6.29M |
| 4 |
RTX Corp
RTX
|
$5.96M |
| 5 |
Merck
MRK
|
$5.73M |
Top Sells
| 1 |
PepsiCo
PEP
|
$4.32M |
| 2 |
AbbVie
ABBV
|
$4.27M |
| 3 |
Adobe
ADBE
|
$3.86M |
| 4 |
Procter & Gamble
PG
|
$3.57M |
| 5 |
Charles Schwab
SCHW
|
$3.48M |
Sector Composition
| 1 | Technology | 17.17% |
| 2 | Consumer Discretionary | 13.96% |
| 3 | Healthcare | 13.8% |
| 4 | Financials | 12.49% |
| 5 | Industrials | 11.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Pinnacle West Capital
PNW
$10.6B
| $290K | 0.05% |
+4,496
| New | +$290K |
|
377
Houlihan Lokey
HLI
$13.9B
| $289K | 0.05% |
3,831
-4,840
| -56% | -$365K |
|
378
Rexford Industrial Realty
REXR
$10.2B
| $289K | 0.05% |
5,567
-3,269
| -37% | -$170K |
|
379
Essent Group
ESNT
$6.29B
| $287K | 0.05% |
8,230
-2,853
| -26% | -$99.5K |
|
380
Bio-Techne
TECH
$8.46B
| $287K | 0.05% |
4,040
-1,664
| -29% | -$118K |
|
381
Western Alliance Bancorporation
WAL
$10B
| $286K | 0.05% |
+4,347
| New | +$286K |
|
382
LegalZoom.com
LZ
$1.86B
| $282K | 0.05% |
32,881
+217
| +0.7% | +$1.86K |
|
383
Chegg
CHGG
$185M
| $278K | 0.05% |
13,175
-15,524
| -54% | -$328K |
|
384
Matsons
MATX
$3.36B
| $277K | 0.05% |
+4,502
| New | +$277K |
|
385
Evertec
EVTC
$2.21B
| $275K | 0.05% |
8,762
+1,011
| +13% | +$31.7K |
|
386
Live Nation Entertainment
LYV
$37.9B
| $275K | 0.05% |
3,622
-3,470
| -49% | -$263K |
|
387
Concentrix
CNXC
$3.39B
| $273K | 0.05% |
+2,443
| New | +$273K |
|
388
Amicus Therapeutics
FOLD
$2.46B
| $273K | 0.05% |
+26,134
| New | +$273K |
|
389
Robinhood
HOOD
$90B
| $272K | 0.05% |
26,904
-45,357
| -63% | -$459K |
|
390
Frontier Group Holdings
ULCC
$1.18B
| $271K | 0.05% |
+27,916
| New | +$271K |
|
391
Clear Secure
YOU
$3.35B
| $271K | 0.05% |
+11,868
| New | +$271K |
|
392
Apellis Pharmaceuticals
APLS
$3.55B
| $267K | 0.05% |
+3,911
| New | +$267K |
|
393
Greif
GEF
$3.57B
| $265K | 0.05% |
+4,456
| New | +$265K |
|
394
Vulcan Materials
VMC
$39B
| $264K | 0.05% |
1,671
-1,137
| -40% | -$180K |
|
|
MDC
395
DELISTED
M.D.C. Holdings, Inc.
MDC
| $264K | 0.05% |
+9,645
| New | +$264K |
|
396
Viavi Solutions
VIAV
$2.6B
| $263K | 0.05% |
+20,168
| New | +$263K |
|
397
Nordson
NDSN
$12.6B
| $262K | 0.05% |
+1,233
| New | +$262K |
|
398
BioCryst Pharmaceuticals
BCRX
$1.74B
| $259K | 0.05% |
+20,523
| New | +$259K |
|
399
Cytokinetics
CYTK
$6.34B
| $259K | 0.05% |
+5,341
| New | +$259K |
|
400
MaxLinear
MXL
$1.36B
| $258K | 0.05% |
7,916
+70
| +0.9% | +$2.28K |
|